Product
simufilam
2 clinical trials
2 indications
Indication
Alzheimer's DiseaseIndication
Healthy Control ParticipantsClinical trial
An Open-Label Extension of the PTI-125-04 Study Evaluating the Safety and Long-Term Treatment of Simufilam in Mild-to-Moderate Alzheimer's Disease PatientsStatus: Active (not recruiting), Estimated PCD: 2025-10-29
Clinical trial
A Four-way Crossover Food Effect and Bioequivalence Pharmacokinetic Study of Simufilam in Healthy VolunteersStatus: Completed, Estimated PCD: 2021-05-11